Literature DB >> 21847800

Utilizing Medicare claims data for real‐time drug safety evaluations:is it feasible?

Abraham G Hartzema1, Judith A Racoosin, Thomas E MaCurdy, Jonathan M Gibbs, Jeffrey A Kelman.   

Abstract

PURPOSE: The Centers for Medicare & Medicaid Services claims comprise an administrative database of beneficiary-specific clinical information. This study evaluates the impacts of (i) claim information updates (claims adjudication) and (ii) delay in claim processing (claims delay) on real-time evaluation of health service and drug safety signals using the Medicare database.
METHODS: Using Medicare claims data accumulated through May 2009 on health services rendered in 2006 and drugs dispensed in 2007, this study measures the frequency with which clinical information changes in the database as a result of (i) claims adjudication and (ii) claims delay.
RESULTS: Over 85% of health services claims were processed within 8 weeks after the date of service, and 72% of drug claims were processed within 3 months after the dispense date. Clinical information changed for no more than 3% of unique claim groups in inpatient hospital, outpatient institutional, physician's office, and prescription drug Medicare claim settings.
CONCLUSIONS: Claims delay is consistent across time and is minimal. Claims adjudication does not substantially impact the content of clinical information in the Medicare claims database. Therefore, the Medicare claims database provides consistent information regarding health services and prescription drugs in a manner that is prompt enough to facilitate medical product safety evaluations in real time.

Entities:  

Mesh:

Year:  2011        PMID: 21847800     DOI: 10.1002/pds.2143

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  7 in total

1.  Evaluating performance of electronic healthcare records and spontaneous reporting data in drug safety signal detection.

Authors:  Vaishali K Patadia; Martijn J Schuemie; Preciosa Coloma; Ron Herings; Johan van der Lei; Sabine Straus; Miriam Sturkenboom; Gianluca Trifirò
Journal:  Int J Clin Pharm       Date:  2014-12-09

2.  Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual.

Authors:  Taliser R Avery; Martin Kulldorff; Yury Vilk; Lingling Li; T Craig Cheetham; Sascha Dublin; Robert L Davis; Liyan Liu; Lisa Herrinton; Jeffrey S Brown
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-02-12       Impact factor: 2.890

3.  Accuracy of Computable Phenotyping Approaches for SARS-CoV-2 Infection and COVID-19 Hospitalizations from the Electronic Health Record.

Authors:  Rohan Khera; Bobak J Mortazavi; Benjamin D Pollock; Wade L Schulz; Veer Sangha; Frederick Warner; H Patrick Young; Joseph S Ross; Nilay D Shah; Elitza S Theel; William G Jenkinson; Camille Knepper; Karen Wang; David Peaper; Richard A Martinello; Cynthia A Brandt; Zhenqiu Lin; Albert I Ko; Harlan M Krumholz
Journal:  medRxiv       Date:  2021-05-13

4.  Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study.

Authors:  Luca Degli Esposti; Diego Sangiorgi; Claudio Mencacci; Edoardo Spina; Carlotta Pasina; Marianna Alacqua; Flore la Tour
Journal:  BMC Psychiatry       Date:  2014-10-14       Impact factor: 3.630

5.  Safety and Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists: Pilot Implementation of a Near-Real-Time Monitoring Program in Italy.

Authors:  Flavia Mayer; Ursula Kirchmayer; Paola Coletta; Nera Agabiti; Valeria Belleudi; Giovanna Cappai; Mirko Di Martino; Sebastian Schneeweiss; Marina Davoli; Elisabetta Patorno
Journal:  J Am Heart Assoc       Date:  2018-03-10       Impact factor: 5.501

6.  Temporal relationship of computed and structured diagnoses in electronic health record data.

Authors:  Wade L Schulz; H Patrick Young; Andreas Coppi; Bobak J Mortazavi; Zhenqiu Lin; Raymond A Jean; Harlan M Krumholz
Journal:  BMC Med Inform Decis Mak       Date:  2021-02-17       Impact factor: 2.796

7.  A multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations.

Authors:  Rohan Khera; Bobak J Mortazavi; Veer Sangha; Frederick Warner; H Patrick Young; Joseph S Ross; Nilay D Shah; Elitza S Theel; William G Jenkinson; Camille Knepper; Karen Wang; David Peaper; Richard A Martinello; Cynthia A Brandt; Zhenqiu Lin; Albert I Ko; Harlan M Krumholz; Benjamin D Pollock; Wade L Schulz
Journal:  NPJ Digit Med       Date:  2022-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.